Detalhe da pesquisa
1.
Integrative Metabolomic and Transcriptomic Analyses Reveal the Mechanism of Petal Blotch Formation in Rosa persica.
Int J Mol Sci
; 25(7)2024 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38612838
2.
Integrated metabolome and transcriptome analysis of the anthocyanin biosynthetic pathway in relation to color mutation in miniature roses.
BMC Plant Biol
; 21(1): 257, 2021 Jun 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34088264
3.
Metabolome-Based Discrimination Analysis of Five Lilium Bulbs Associated with Differences in Secondary Metabolites.
Molecules
; 26(5)2021 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33801551
4.
[18F]-Alfatide PET imaging of integrin αvß3 for the non-invasive quantification of liver fibrosis.
J Hepatol
; 73(1): 161-169, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32145257
5.
Combined 68Ga-NOTA-Evans Blue Lymphoscintigraphy and 68Ga-NOTA-RM26 PET/CT Evaluation of Sentinel Lymph Node Metastasis in Breast Cancer Patients.
Bioconjug Chem
; 31(2): 396-403, 2020 02 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-31880916
6.
A Metabolically Stable Boron-Derived Tyrosine Serves as a Theranostic Agent for Positron Emission Tomography Guided Boron Neutron Capture Therapy.
Bioconjug Chem
; 30(11): 2870-2878, 2019 11 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31593447
7.
Improving the Theranostic Potential of Exendin 4 by Reducing the Renal Radioactivity through Brush Border Membrane Enzyme-Mediated Degradation.
Bioconjug Chem
; 30(6): 1745-1753, 2019 06 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-31181890
8.
An Albumin-Binding T1- T2 Dual-Modal MRI Contrast Agents for Improved Sensitivity and Accuracy in Tumor Imaging.
Bioconjug Chem
; 30(6): 1821-1829, 2019 06 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-31117347
9.
An Albumin Sandwich Enhances in Vivo Circulation and Stability of Metabolically Labile Peptides.
Bioconjug Chem
; 30(6): 1711-1723, 2019 06 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-31082207
10.
68Ga-NOTA-Aca-BBN(7-14) PET imaging of GRPR in children with optic pathway glioma.
Eur J Nucl Med Mol Imaging
; 46(10): 2152-2162, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31270559
11.
Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial.
Lancet
; 389(10088): 2492-2502, 2017 Jun 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-28434648
12.
Single Low-Dose Injection of Evans Blue Modified PSMA-617 Radioligand Therapy Eliminates Prostate-Specific Membrane Antigen Positive Tumors.
Bioconjug Chem
; 29(9): 3213-3221, 2018 09 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-30105912
13.
Positron Emission Tomography Imaging of Prostate Cancer with Ga-68-Labeled Gastrin-Releasing Peptide Receptor Agonist BBN7-14 and Antagonist RM26.
Bioconjug Chem
; 29(2): 410-419, 2018 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-29254329
14.
Predictive probability methods for interim monitoring in clinical trials with longitudinal outcomes.
Stat Med
; 37(14): 2187-2207, 2018 06 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-29664214
15.
In vivo albumin labeling and lymphatic imaging.
Proc Natl Acad Sci U S A
; 112(1): 208-13, 2015 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-25535368
16.
Microsurgery guided by sequential preoperative lymphography using 68Ga-NEB PET and MRI in patients with lower-limb lymphedema.
Eur J Nucl Med Mol Imaging
; 44(9): 1501-1510, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28382512
17.
Stable Evans Blue Derived Exendin-4 Peptide for Type 2 Diabetes Treatment.
Bioconjug Chem
; 27(1): 54-8, 2016 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-26641886
18.
(18)F-Alfatide II PET/CT in healthy human volunteers and patients with brain metastases.
Eur J Nucl Med Mol Imaging
; 42(13): 2021-8, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26121930
19.
Stability analysis of glutamic acid linked peptides coupled to NOTA through different chemical linkages.
Mol Pharm
; 11(11): 3867-74, 2014 Nov 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-24533430
20.
Development of a new thiol site-specific prosthetic group and its conjugation with [Cys(40)]-exendin-4 for in vivo targeting of insulinomas.
Bioconjug Chem
; 24(7): 1191-200, 2013 Jul 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-23750453